178 related articles for article (PubMed ID: 26443715)
1. Epigenetics in Legg-Calvé-Perthes disease: A study of global DNA methylation.
Zheng P; Yang T; Ju L; Jiang B; Lou Y
J Int Med Res; 2015 Dec; 43(6):758-64. PubMed ID: 26443715
[TBL] [Abstract][Full Text] [Related]
2. Role of leptin in Legg-Calvé-Perthes disease.
Lee JH; Zhou L; Kwon KS; Lee D; Park BH; Kim JR
J Orthop Res; 2013 Oct; 31(10):1605-10. PubMed ID: 23832827
[TBL] [Abstract][Full Text] [Related]
3. Increased soluble selectins as a reflection of activated platelets and endothelium in Legg-Calve-Perthes disease.
Ismayilov V; Aksoy DY; Sayinalp N; Haznedaroğlu IC; Aksoy MC
J Pediatr Hematol Oncol; 2014 Oct; 36(7):e410-1. PubMed ID: 25000467
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.
Gaughan DM; Mofenson LM; Hughes MD; Seage GR; Ciupak GL; Oleske JM;
Pediatrics; 2002 May; 109(5):E74-4. PubMed ID: 11986480
[TBL] [Abstract][Full Text] [Related]
5. Legg-Calve-Perthes disease in two generations of male family members: a case report.
Al-Omran AK; Sadat-Ali M
J Orthop Surg (Hong Kong); 2013 Aug; 21(2):258-61. PubMed ID: 24014797
[TBL] [Abstract][Full Text] [Related]
6. Legg-Calvé-Perthes disease overview.
Rodríguez-Olivas AO; Hernández-Zamora E; Reyes-Maldonado E
Orphanet J Rare Dis; 2022 Mar; 17(1):125. PubMed ID: 35292045
[TBL] [Abstract][Full Text] [Related]
7. Vascular safe zones for surgical dislocation in children with healed Legg-Calvé-Perthes disease.
Shore BJ; Millis MB; Kim YJ
J Bone Joint Surg Am; 2012 Apr; 94(8):721-7. PubMed ID: 22517388
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Association between Legg-Calvé-Perthes Disease and Attention Deficit Hyperactivity Disorder in Children.
Berman J; Aran A; Berenstein-Weyel T; Lebel E
Isr Med Assoc J; 2016 Nov; 18(11):652-654. PubMed ID: 28466612
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin and GFC levels in Legg-Calve-Perthes disease.
Aksoy MC; Aksoy DY; Haznedaroglu IC; Sayinalp N; Kirazli S; Alpaslan M
Hematology; 2008 Dec; 13(6):324-8. PubMed ID: 19055859
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of serum proteomes in Legg-Calve-Perthes disease.
Liu R; Fan L; Yin L; Wang K; Miao W; Song Q; Dang X; Gao H; Bai C
BMC Musculoskelet Disord; 2015 Oct; 16():281. PubMed ID: 26438379
[TBL] [Abstract][Full Text] [Related]
11. Skeletal immaturity, IGF-I and IGFBP-3 serum concentrations in Legg-Calvé-Perthes disease (skeletal immaturity, IGF-I and IGFBP-3 in LCPD).
Grasemann H; Nicolai RD; Hauffa BP; Reinhardt W; Nicolai H; Hövel M
Klin Padiatr; 1996; 208(6):339-43. PubMed ID: 8962421
[TBL] [Abstract][Full Text] [Related]
12. Serum prolidase activity and oxidative-antioxidative status in Legg-Calve-Perthes disease.
Altay MA; Erturk C; Aksoy N; Taskin A; Bilge A; Celik H; Isikan UE
J Pediatr Orthop B; 2011 Jul; 20(4):222-6. PubMed ID: 21304409
[TBL] [Abstract][Full Text] [Related]
13. Alterations of serum osteocalcin levels in patients with Legg-Calvé-Perthes.
Wei WB; Dang SJ; Li Y; Liu ZZ
Hip Int; 2017 Feb; 27(1):92-95. PubMed ID: 27886352
[TBL] [Abstract][Full Text] [Related]
14. What are the Demographics and Epidemiology of Legg-Calvé-Perthes Disease in a Large Southern California Integrated Health System?
Kessler JI; Cannamela PC
Clin Orthop Relat Res; 2018 Dec; 476(12):2344-2350. PubMed ID: 30211706
[TBL] [Abstract][Full Text] [Related]
15. Association of IL-6 -174G > C and -572G > C Polymorphisms with Risk of Legg-Calve-Perthes Disease in Iranian Children.
Akbarian-Bafghi MJ; Dastgheib SA; Morovati-Sharifabad M; Sobhan MR; Moghimi M; Mahdinezhad-Yazdi M; Lookzadeh MH; Khajehnoori S; Neamatzadeh H
Fetal Pediatr Pathol; 2021 Jun; 40(3):206-213. PubMed ID: 31757175
[TBL] [Abstract][Full Text] [Related]
16. Female patients with late-onset legg-calvé-perthes disease are frequently gymnasts: is there a mechanical etiology for this subset of patients?
Larson AN; Kim HK; Herring JA
J Pediatr Orthop; 2013 Dec; 33(8):811-5. PubMed ID: 24065070
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA sequence analysis of plasma exosomes in early Legg-Calvé-Perthes disease.
Huang Q; Li B; Lin C; Chen X; Wang T; Liu J; Liu Y; Lu R; Liao S; Ding X
Cell Signal; 2022 Mar; 91():110184. PubMed ID: 34740784
[TBL] [Abstract][Full Text] [Related]
18. The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes disease.
Kenet G; Hayek S; Mor M; Lubetsky A; Miller L; Rosenberg N; Mosheiff R; Itzchaki M; Elstein D; Wientroub S; Zimran A
Blood Cells Mol Dis; 2003; 31(1):72-4. PubMed ID: 12850487
[TBL] [Abstract][Full Text] [Related]
19. Legg-Calvé-perthes disease: quality of life, physical activity, and behavior pattern.
Hailer YD; Haag AC; Nilsson O
J Pediatr Orthop; 2014; 34(5):514-21. PubMed ID: 24787306
[TBL] [Abstract][Full Text] [Related]
20. Environmental tobacco and wood smoke increase the risk of Legg-Calvé-Perthes disease.
Daniel AB; Shah H; Kamath A; Guddettu V; Joseph B
Clin Orthop Relat Res; 2012 Sep; 470(9):2369-75. PubMed ID: 22090357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
